NcRNAs in Type-2 Immunity

Overview

Journal Noncoding RNA

Date 2020 Mar 12

PMID 32155783

Citations 10

Authors

Riccardo Guidi

Christopher J Wedeles

Mark S Wilson

Affiliations

Soon will be listed here.

Abstract

Immunological diseases, including asthma, autoimmunity and immunodeficiencies, affect a growing percentage of the population with significant unmet medical needs. As we slowly untangle and better appreciate these complex genetic and environment-influenced diseases, new therapeutically targetable pathways are emerging. Non-coding RNA species, which regulate epigenetic, transcriptional and translational responses are critical regulators of immune cell development, differentiation and effector function, and may represent one such new class of therapeutic targets. In this review we focus on type-2 immune responses, orchestrated by T2 cell-derived cytokines, IL-4, IL-5 and IL-13, which stimulate a variety of immune and tissue responses- commonly referred to as type-2 immunity. Evolved to protect us from parasitic helminths, type-2 immune responses are observed in individuals with allergic diseases, including Asthma, atopic dermatitis and food allergy. A growing number of studies have identified the involvement of various RNA species, including microRNAs (miRNA) and long non-coding (lncRNA), in type-2 immune responses and in both clinical and pre-clinical disease settings. We highlight these recent findings, identify gaps in our understanding and provide a perspective on how our current understanding can be harnessed for novel treat opportunities to treat type-2 immune-mediated diseases.

Citing Articles

Unraveling the microRNAs Involved in Fasciolosis: Master Regulators of the Host-Parasite Crosstalk.

Barrero-Torres D, Herrera-Torres G, Perez J, Martinez-Moreno A, Martinez-Moreno F, Flores-Velazquez L Int J Mol Sci. 2025; 26(1.

PMID: 39796061 PMC: 11719827. DOI: 10.3390/ijms26010204.

MiRNA-based therapeutic potential in multiple sclerosis.

Zabalza A, Pappolla A, Comabella M, Montalban X, Malhotra S Front Immunol. 2024; 15:1441733.

PMID: 39267760 PMC: 11390414. DOI: 10.3389/fimmu.2024.1441733.

LINC00998 Modulating M2 Macrophage Activation in Allergic Rhinitis by Stabilizing BOB.1 mRNA.

He Y, Tang Y, Wen S, Dong L, Li F, Deng Y J Inflamm Res. 2024; 17:2309-2326.

PMID: 38638161 PMC: 11026101. DOI: 10.2147/JIR.S444692.

lncRNA FR215775 Regulates Th2 Differentiation in Murine Allergic Rhinitis.

Ma Y, Shi L, Zhao K, Zheng C J Immunol Res. 2022; 2022:7783481.

PMID: 35755169 PMC: 9214652. DOI: 10.1155/2022/7783481.

MALAT1 Induces Food Allergy by Promoting Release of IL-6 from Dendritic Cells and Suppressing the Immunomodulatory Function of Tregs.

Feng H, Xiong X, Chen Z, Luo N, Wu Y J Asthma Allergy. 2022; 15:529-544.

PMID: 35515816 PMC: 9064454. DOI: 10.2147/JAA.S341742.

References

Zelante T, De Luca A, DAngelo C, Moretti S, Romani L . IL-17/Th17 in anti-fungal immunity: what's new?. Eur J Immunol. 2009; 39(3):645-8. DOI: 10.1002/eji.200839102. View

Vigorito E, Perks K, Abreu-Goodger C, Bunting S, Xiang Z, Kohlhaas S . microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity. 2007; 27(6):847-59. PMC: 4135426. DOI: 10.1016/j.immuni.2007.10.009. View

Soumelis V, Reche P, Kanzler H, Yuan W, Edward G, Homey B . Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol. 2002; 3(7):673-80. DOI: 10.1038/ni805. View

Zhuang G, Meng C, Guo X, Cheruku P, Shi L, Xu H . A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation. Circulation. 2012; 125(23):2892-903. DOI: 10.1161/CIRCULATIONAHA.111.087817. View

Min B, Prout M, Hu-Li J, Zhu J, Jankovic D, Morgan E . Basophils produce IL-4 and accumulate in tissues after infection with a Th2-inducing parasite. J Exp Med. 2004; 200(4):507-17. PMC: 2211939. DOI: 10.1084/jem.20040590. View

Veldhoen M, Uyttenhove C, Van Snick J, Helmby H, Westendorf A, Buer J . Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol. 2008; 9(12):1341-6. DOI: 10.1038/ni.1659. View

Chu F, Hu Y, Zhou Y, Guo M, Lu J, Zheng W . MicroRNA-126 deficiency enhanced the activation and function of CD4 T cells by elevating IRS-1 pathway. Clin Exp Immunol. 2017; 191(2):166-179. PMC: 5758368. DOI: 10.1111/cei.13067. View

Bronevetsky Y, Villarino A, Eisley C, Barbeau R, Barczak A, Heinz G . T cell activation induces proteasomal degradation of Argonaute and rapid remodeling of the microRNA repertoire. J Exp Med. 2013; 210(2):417-32. PMC: 3570096. DOI: 10.1084/jem.20111717. View

Conti H, Shen F, Nayyar N, Stocum E, Sun J, Lindemann M . Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med. 2009; 206(2):299-311. PMC: 2646568. DOI: 10.1084/jem.20081463. View

10.

Lee H, Lee H, Choi J, Hur J, Kim I, Kim Y . Inhibition of MicroRNA-21 by an antagomir ameliorates allergic inflammation in a mouse model of asthma. Exp Lung Res. 2017; 43(3):109-119. DOI: 10.1080/01902148.2017.1304465. View

11.

Neill D, Wong S, Bellosi A, Flynn R, Daly M, Langford T . Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature. 2010; 464(7293):1367-70. PMC: 2862165. DOI: 10.1038/nature08900. View

12.

Kozomara A, Birgaoanu M, Griffiths-Jones S . miRBase: from microRNA sequences to function. Nucleic Acids Res. 2018; 47(D1):D155-D162. PMC: 6323917. DOI: 10.1093/nar/gky1141. View

13.

Josefowicz S, Lu L, Rudensky A . Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol. 2012; 30:531-64. PMC: 6066374. DOI: 10.1146/annurev.immunol.25.022106.141623. View

14.

Han X, Huang S, Xue P, Fu J, Liu L, Zhang C . LncRNA modulates M2 macrophage activation and inflammatory diseases by epigenetic promotion of PTPRE. Sci Adv. 2019; 5(12):eaax9230. PMC: 6905863. DOI: 10.1126/sciadv.aax9230. View

15.

Hosokawa H, Ungerback J, Wang X, Matsumoto M, Nakayama K, Cohen S . Transcription Factor PU.1 Represses and Activates Gene Expression in Early T Cells by Redirecting Partner Transcription Factor Binding. Immunity. 2018; 48(6):1119-1134.e7. PMC: 6063530. DOI: 10.1016/j.immuni.2018.04.024. View

16.

Chong M, Rasmussen J, Rudensky A, Rundensky A, Littman D . The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease. J Exp Med. 2008; 205(9):2005-17. PMC: 2526196. DOI: 10.1084/jem.20081219. View

17.

Pang K, Frith M, Mattick J . Rapid evolution of noncoding RNAs: lack of conservation does not mean lack of function. Trends Genet. 2005; 22(1):1-5. DOI: 10.1016/j.tig.2005.10.003. View

18.

Lu L, Boldin M, Chaudhry A, Lin L, Taganov K, Hanada T . Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell. 2010; 142(6):914-29. PMC: 3049116. DOI: 10.1016/j.cell.2010.08.012. View

19.

Liston A, Lu L, OCarroll D, Tarakhovsky A, Rudensky A . Dicer-dependent microRNA pathway safeguards regulatory T cell function. J Exp Med. 2008; 205(9):1993-2004. PMC: 2526195. DOI: 10.1084/jem.20081062. View

20.

Tykocinski L, Hajkova P, Chang H, Stamm T, Sozeri O, Lohning M . A critical control element for interleukin-4 memory expression in T helper lymphocytes. J Biol Chem. 2005; 280(31):28177-85. DOI: 10.1074/jbc.M502038200. View